Jacobson & Schmitt Advisors’s AbbVie ABBV Stock Holding History

Jacobson & Schmitt Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$487K	Sell	1,935 -124	-6%	-$26.7K	0.08%	62
2026 Q1	$448K	Hold	2,059	–	–	0.08%	59
2025 Q4	$470K	Sell	2,059 -382	-16%	-$87K	0.08%	57
2025 Q3	$565K	Buy	2,441 +410	+20%	+$83.5K	0.1%	55
2025 Q2	$377K	Buy	+2,031	New	+$377K	0.07%	59
2025 Q1	–	Sell	-2,031	Closed	-$361K	–	44
2024 Q4	$361K	Hold	2,031	–	–	0.07%	61
2024 Q3	$401K	Sell	2,031 -21	-1%	-$3.92K	0.08%	54
2024 Q2	$352K	Buy	+2,052	New	+$340K	0.08%	52
2024 Q1	–	Sell	-1,800	Closed	-$279K	–	46
2023 Q4	$279K	Sell	1,800 -100	-5%	-$14.6K	0.07%	57
2023 Q3	$283K	Buy	1,900 +100	+6%	+$14.7K	0.08%	47
2023 Q2	$243K	Hold	1,800	–	–	0.07%	55
2023 Q1	$287K	Hold	1,800	–	–	0.08%	50
2022 Q4	$242K	Hold	1,800	–	–	0.08%	45
2022 Q3	$242K	Hold	1,800	–	–	0.08%	45
2022 Q2	$276K	Hold	1,800	–	–	0.09%	42
2022 Q1	$292K	Hold	1,800	–	–	0.08%	46
2021 Q4	$244K	Buy	+1,800	New	+$213K	0.06%	54

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jacobson & Schmitt Advisors's ABBV Position: Q2 2026 in Review

Jacobson & Schmitt Advisors reduced its AbbVie (ABBV) stake by 6% in Q2 2026, selling an estimated $26.7K and leaving 1,935 shares worth $487K. The position accounts for 0.08% of the portfolio, ranked #62.

Jacobson & Schmitt Advisors first reported a position in ABBV in Q4 2021 and has held it in 17 quarters since. The position peaked at $565K in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Jacobson & Schmitt Advisors held 1,935 shares of AbbVie worth $487K as of Q2 2026.
Jacobson & Schmitt Advisors sold 124 AbbVie shares in Q2 2026, an estimated $26.7K.
AbbVie made up 0.08% of Jacobson & Schmitt Advisors's portfolio in Q2 2026, its #62 holding.
Jacobson & Schmitt Advisors first reported a position in AbbVie in Q4 2021 and has held it in 17 quarters since.
Jacobson & Schmitt Advisors's AbbVie position peaked at $565K in Q3 2025.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Jacobson & Schmitt Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.